Clinical Gastroenterology and Hepatology

Papers
(The H4-Index of Clinical Gastroenterology and Hepatology is 70. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease406
Reply314
Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care215
Endoscopic Polypectomy: How Should We Determine Complete Resection Status?206
Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?205
Simplifying ADR Reporting: A Worthy Goal, but the Devil is in the Details202
An Unexpected Subepithelial Lesion: Catching the Diagnosis Earlier!195
Reply177
Gastric Emphysema With Hepatic Portal Venous Gas Secondary to Acute Gastric Mucosal Lesion164
Editorial Board158
Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study156
Attribution of Colonoscopy Risk Does Not FIT!152
Exam 1: Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis145
Table of Contents143
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward139
Cover139
Issue Highlights137
Elsewhere in the AGA Journals134
Correction130
Hepatic Artery Pseudoaneurysm After Whipple Procedure129
FODMAPs in IBS: Revisiting Restriction127
Blue Notes126
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?116
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment109
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials108
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial108
Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling107
Front Cover106
Editorial Board106
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis105
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease103
Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis100
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicentre, Sham-controlled, Randomized Trial99
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort97
Gut Microbiome Modulation by Antibiotics in Adult Asthma: A Human Proof-of-Concept Intervention Trial94
Ambulatory Acute Kidney Injury in Patients with Cirrhosis is Common and Burdensome93
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy91
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?91
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis87
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum86
A Case of Pedunculated Esophageal Neuroendocrine Tumor G185
An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI85
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study85
HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy85
Reply85
Assessment and Significance of Histologic Activity in Crohn’s Disease84
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants83
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis83
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia83
Hyperbaric Oxygen Therapy Is Effective in the Treatment of Inflammatory and Fistulizing Pouch Complications83
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease82
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study81
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability81
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States81
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study80
Long-term Effectiveness and Safety of Risankizumab in Patients with Crohn’s Disease80
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction80
The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy76
In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent76
AGA Clinical Practice Update on Endoscopic Management of Perforations in Gastrointestinal Tract: Expert Review75
Update in the Treatment of the Complications of Cirrhosis75
An Unsuccessful Randomized Trial of Percutaneous vs Endoscopic Drainage of Suspected Malignant Hilar Obstruction75
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis74
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary74
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels74
PErsistence and safety of subcutaneous infliximab 1 year after switch from intravenous route in IBD patients in REMission73
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States72
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease71
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study71
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn’s Disease: A Systematic Review and Meta-analysis70
0.21399402618408